On the daily chart the 50 SMA has sat below the 200 since Mar, and price is trading below both. No cross is projected on the daily or the weekly inside the 30 bars we track.
On the daily, NEAR has crossed 19 times, roughly every 6 months, the last one on 3/23/2026. On the weekly it has crossed 3 times, most recently a golden cross in Jan 2024, with price trading above the 50/200 cross point that day. It ended the following week where it started.
Loading the chart...
29 golden and death crosses since 2017, with 3 on the weekly timeframe. 2025 alone holds eight of the 19 daily crosses. Of the 19 daily crosses tracked, we projected 17 of them from a median of 19 bars out. It has not crossed on any timeframe since 3/23/2026.
| Crossed | ||
|---|---|---|
| 3/23/2026 | Death | daily |
| 3/9/2026 | Death | 4-hour |
| 2/23/2026 | Golden | 4-hour |
| 12/9/2025 | Death | 4-hour |
| 6/17/2025 | Golden | daily |
| 6/16/2025 | Death | daily |
| 6/13/2025 | Golden | daily |
| 6/2/2025 | Death | daily |
| 5/30/2025 | Golden | daily |
| 5/9/2025 | Death | daily |
| 4/30/2025 | Golden | daily |
| 3/4/2025 | Golden | 4-hour |
| 2/4/2025 | Death | daily |
| 11/11/2024 | Death | 4-hour |
| 7/12/2024 | Golden | daily |
| 7/9/2024 | Golden | 4-hour |
| 6/4/2024 | Death | daily |
| 4/2/2024 | Death | 4-hour |
| 1/5/2024 | Golden | weekly |
| 1/27/2023 | Golden | daily |
| 3/4/2022 | Death | weekly |
| 7/16/2021 | Death | daily |
| 4/30/2021 | Golden | weekly |
| 7/27/2020 | Golden | daily |
| 3/13/2020 | Death | daily |
| 3/22/2019 | Golden | daily |
| 10/24/2018 | Death | daily |
| 9/24/2018 | Golden | daily |
| 12/7/2017 | Death | daily |
No crosses on record for that combination.
Click any cross on the chart above for its lead time. Crosses from 2 September 2026 onward were watched live; earlier ones are replayed from the archive with no look-ahead, which is the same method behind the published track record.
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.